Ergoline is a chemical compound whose structural skeleton is contained in a diverse range of alkaloids and a few psychedelic drugs (ololiuhqui, LSD). Ergoline derivatives are used clinically for the purpose of vasoconstriction (5-HT1 receptor agonists - ergotamine) and in the treatment of migraine (used with caffeine) and Parkinson's disease, some are implicated in the disease ergotism. Ergometrine and ergotamine are listed as Table I precursors under the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
The relationship between these compounds is summarized in the following structural formula and table of substitutions.
| Name | R1 | R2 | R3 |
|---|---|---|---|
| Ergine | H | H | H |
| Ergonovine | H | CH(CH3)CH2OH | H |
| Methergine | H | CH(CH2CH3)CH2OH | H |
| Methysergide | CH3 | CH(CH2CH3)CH2OH | H |
| LSD | H | CH2CH3 | CH2CH3 |
| Name | R1 | R2 | R3 |
|---|---|---|---|
| Ergotamine | CH3 | benzyl | |
| Ergocristine | CH(CH3)2 | benzyl | |
| Ergocornine | CH(CH3)2 | CH(CH3)2 | |
| Ergocryptine | CH(CH3)2 | CH2CH(CH3)2 | |
| Bromocriptine | Br | CH(CH3)2 | CH2CH(CH3)2 |
| Ergovaline | CH3 | CH(CH3)2 |
With the determination of the basic chemical structure of the ergot alkaloids in the early 1930s, an era of intensive exploration of synthetic derivatives began. In addition to the naturally occurring ergonovine (used as an oxytocic) and ergotamine (a vasoconstrictor used to control migraine), synthetic derivatives of continuing importance today are the oxytocic methergine, the anti-migraine drugs dihydroergotamine and methysergide, Hydergine (a mixture of dihydroergotoxine mesylates, INN: ergoline mesylates), and bromocriptine, used for numerous purposes including treatment of Parkinson's disease. Newer synthetic ergolines used for Parkinson's disease include pergolide and lisuride. Perhaps the most famous ergoline derivative of all is the psychedelic drug LSD.
In 1960, Albert Hofmann (discoverer of methergine, dihydroergotamine, Hydergine and lysergic acid diethylamide) delivered a speech that was to cause shockwaves of incredulity and disbelief in the scientific community. Ergoline alkaloids, previously only known from the lower fungi, had been found in two species of flowering plants. These were the Mexican species Rivea corymbosa and Ipomoea violacea of the Convolvulaceae (morning glory) family, the seeds of which were identified as the psychedelic plant drugs known as "ololiuhqui" and "tlitliltzin". Hofmann's result was later confirmed by other studies. The principal alkaloids in the seeds are ergine and its optical isomer isoergine, with several other lysergic acid derivatives and clavines present in lesser amounts. The Hawaiian species Argyreia nervosa was later found to include similar alkaloids. It is possible, though not proven, that ergine or isoergine are responsible for the hallucinogenic effects. However, while Hofmann's discovery is an important landmark in the research of ergot alkaloids, a recent study has provided evidence for a fungal origin of the ergoline alkaloids also in the Convolvulaceae. Like the ergot alkaloids in some monocot plants, the ergoline alkaloids found in the plant Ipomoea asarifolia (Convolvulaceae) are produced by a seed-transmitted epiphytic clavicipitaceous fungus.